Intensive cardiovascular risk reduction induces sustainable changes in expression of genes and pathways important to vascular function.
Ellsworth DL, Croft DT Jr, Weyandt J, Sturtz LA, Blackburn HL, Burke A, Haberkorn MJ, McDyer FA, Jellema GL, van Laar R, Mamula KA, Chen Y, Vernalis MN.
Ellsworth DL, et al. Among authors: van laar r.
Circ Cardiovasc Genet. 2014 Apr;7(2):151-60. doi: 10.1161/CIRCGENETICS.113.000121. Epub 2014 Feb 21.
Circ Cardiovasc Genet. 2014.
PMID: 24563419
Clinical Trial.